Paraneoplastic neuromyelitis optica spectrum disorders: a case series
- PMID: 33506301
- DOI: 10.1007/s10072-021-05055-y
Paraneoplastic neuromyelitis optica spectrum disorders: a case series
Abstract
Aquaporin-4 antibody (AQP4-IgG) neuromyelitis optica spectrum disorders (NMOSD) are rare idiopathic autoimmune diseases, presenting with optic neuritis (ON), longitudinally extensive transverse myelitis (LETM), and brainstem syndromes and a prevalence range between 0.5 and 4/100,000. Only 3% to 25% of NMOSD have been described as a paraneoplastic (PN) syndrome (PNNMOSD). Both idiopathic NMOSD (INMOSD) and PNNMOSD cases mostly affect females, but PNNMOSD usually presents with a spinal cord or brainstem involvement in elderly patients. Few cases of both malignancies (for the majority breast or lung cancer) and benign tumors (monoclonal gammopathy) were previously reported. Currently, there is no consensus on treatment approach for PNNMOSD (only surgical removal or surgery combined with chronic immunosuppression). Here, we present a series of three newly diagnosed PNNMOSD cases, who differ from each other for demographic and clinical features, tumor association, long-term treatment, and outcome. We propose that a PN etiology should be considered always whenever a new diagnosis of NMOSD is made, not only in patients over 50 years old or in spinal cord/brainstem lesions presentations. Our findings add to existing evidence and raise awareness on PNNMOSD. We enhance the importance for the clinicians of recognizing tumor symptoms and signs whenever a NMOSD is newly diagnosed.
Keywords: Aquaporin-4; Neuromyelitis optica spectrum disorders; Optic neuritis; Paraneoplastic syndrome; Transverse myelitis.
References
-
- Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Sillevis Smitt P, Vedeler CH, Verschuuren JJGM, Vincent A, Voltz R, for the Paraneoplastic Neurological Syndrome Euronetwork (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140. https://doi.org/10.1136/jnnp.2003.034447 - DOI - PubMed - PMC
-
- Zoccarato M, Gastaldi M, Zuliani L, Biagioli T, Brogi M, Bernardi G, Corsini E, Bazzigaluppi E, Fazio R, Giannotta C, Nobile-Orazio E, Costa G, Iorio R, Evoli A, Mariotto S, Ferrari S, Galloni E, De Riva V, Zardini E, Franciotta D, Giometto B (2017) Diagnostics of paraneoplastic neurological syndromes. Neurol Sci 38:237–242. https://doi.org/10.1007/s10072-017-3031-5 - DOI - PubMed
-
- Cai G, He D, Chu L, Dai Q, Xu Z, Zhang Y (2016) Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature. Int J Neurosci 126:660–668. https://doi.org/10.3109/00207454.2015.1054481 - DOI - PubMed
-
- Sepulveda M, Sola-Valls N, Escudero D, Rojc B, Barón M, Hernández-Echebarría L, Gómez B, Dalmau J, Saiz A, Graus F (2017) Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies. Mult Scler 24-13:1753–1759. https://doi.org/10.1177/1352458517731914 - DOI
-
- Beauchemin P, Iorio R, Traboulsee AL, Field T, Tinker AV, Carruthers R (2017) Paraneoplastic neuromyelitis optica spectrum disorder: a single center cohort description with two cases of histological validation. Mult Scler Relat Disord 20:37–42. https://doi.org/10.1016/j.msard.2017.12.012 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous